Literature DB >> 23163273

Update on imaging of the lacrimal drainage system.

Daniel R Lefebvre1, Suzanne K Freitag.   

Abstract

Epiphora is a common problem seen by the ophthalmologist. There are numerous etiologies of a watering eye, and the underlying diagnosis is not always clear. A variety of in-office examination techniques and procedures exist to aid with diagnosis and determination of appropriate therapy, but sometimes the diagnosis remains elusive, or an instituted therapy fails. Lacrimal imaging, particularly in these cases, can be helpful in assessing the function and anatomy of the lacrimal drainage system. This review serves to examine the literature of the last 10 years concerning imaging of the lacrimal drainage system.

Entities:  

Mesh:

Year:  2012        PMID: 23163273     DOI: 10.3109/08820538.2012.711413

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  4 in total

1.  Diagnostic performance of the three-dimensional fast spin echo-Cube sequence in comparison with a conventional imaging protocol in evaluation of the lachrymal drainage system.

Authors:  Jing Zhang; Lang Chen; Qiu-Xia Wang; Rong Liu; Wen-Zhen Zhu; Xin Luo; Li Peng; Wei Xiong
Journal:  Eur Radiol       Date:  2014-10-15       Impact factor: 5.315

2.  Preoperative imaging should be performed prior to surgery in all cases of acquired nasolacrimal obstruction-Yes.

Authors:  S K Freitag; J C P Roos
Journal:  Eye (Lond)       Date:  2016-11-04       Impact factor: 3.775

3.  Nasolacrimal system aeration on computed tomographic imaging: effects of patient positioning and scan orientation.

Authors:  Craig N Czyz; Thomas S Bacon; Andrew W Stacey; Eva N Cahill; Bryan R Costin; Boris I Karanfilov; Kenneth V Cahill
Journal:  Clin Ophthalmol       Date:  2015-03-11

4.  Lacrimal Canaliculus Imaging Using Optical Coherence Tomography Dacryography.

Authors:  Masahiro Fujimoto; Akihito Uji; Ken Ogino; Tadamichi Akagi; Nagahisa Yoshimura
Journal:  Sci Rep       Date:  2018-06-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.